Sin embargo, su uso para trastornos alimentarios especficos como el trastorno de atracones permanece como una aplicacin fuera de indicacin (off-label) que requiere evaluacin cuidadosa
S-Adenosyl-L-Methionine for Treatment of Depression, Osteoarthritis, and Liver Disease
The votes arent binding and the FDA has periodically bucked the recommendations of its outside experts
J Environ Qual 14(2):229233
1 Morgan Stanley, Could Obesity Drugs Take a Bite Out of the Food Industry, 2023 2 Morgan Stanley, 2023 3 The Food Institute, 2024 4 Nestle, First-to-market Vital Pursuit Hits Shelves Nationwide, 2024 5 Grocery Dive, How GLP-1s Could Reshape the Grocery Store, 2025 6 MediaRadar, Weight Loss, Diabetes Drug Ad Spending Tops $1B, 2024 7 McKinsey, What are GLP-1 Medications?, 2025 8 JP Morgan Research, The Increase in Appetite for Obesity Drugs, 2023 9 Cornell University, The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Demand, 2024
Writing in Vox, Stephanie Psaki, who served as the first U.S